JP Morgan Maintains Overweight on Aptiv, Raises Price Target to $84

Benzinga Newsdesk www.benzinga.com Positive 74.0%

Neg 0% Neu 0% Pos 74%

JP Morgan analyst Ryan Brinkman maintains Aptiv (NYSE:APTV) with a Overweight and raises the price target from $83 to $84.